XGN Exagen Inc.

Exagen, Inc. is a commercial-stage diagnostics company. It engages in transforming the care continuum for patients suffering from debilitating and chronic autoimmune diseases by enabling timely differential diagnosis and optimizing therapeutic intervention. The company operates under the Avise brand. Exagen was founded by Waneta C. Tuttle and Cole Harris in 2002 and is headquartered in Vista, CA.

$13.82
As of 09/16/2021     IEX book   CBOE book


Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Diagnostics & Research
Index country:  USA
Country of incorporation:  USA
IPO date:  09/19/2019
Outstanding shares:  16,126,784
Average volume:  61,727
Market cap:   $223,678,494
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    30068X103
ISIN:        US30068X1037
Sedol:      BK4W379
Valuation   (See tab for details)
PE ratio:   -10.94
PB ratio:   2.31
PS ratio:   4.78
Return on equity:   -21.15%
Net income %:   -43.55%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy